Cancer Research CTRC-AACR San Antonio Breast Cancer Symposium  Translational Medicine Conference in Israel
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Draffin, J. E.
Right arrow Articles by Waugh, D. J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Draffin, J. E.
Right arrow Articles by Waugh, D. J. J.
[Cancer Research 64, 5702-5711, August 15, 2004]
© 2004 American Association for Cancer Research


Regular Articles

CD44 Potentiates the Adherence of Metastatic Prostate and Breast Cancer Cells to Bone Marrow Endothelial Cells

Jayne E. Draffin, Suzanne McFarlane, Ashleigh Hill, Patrick G. Johnston and David J. J. Waugh

Department of Oncology, Centre for Cancer Research, Queen’s University Belfast, Belfast City Hospital, Belfast, Northern Ireland

The aim of this current study was to examine the significance of CD44 expression in mediating cancer cell adhesion to human bone marrow endothelial cell(s) (hBMEC). Differential CD44 expression on two metastatic prostate cancer cell lines, PC3 (CD44 +ve) and DU145 (CD44 –ve) and four breast cancer cell lines was confirmed by immunoblotting and immunocytochemistry. In cell adhesion assays, PC3 but not DU145 cells demonstrated a rapid adhesion to hBMECs. Treatment of PC3 cells with a neutralizing antibody against CD44 standard (CD44s) and CD44 splice variants decreased PC3 cell adhesion to hBMECs. Similarly, depletion of CD44 expression using RNA interference decreased the ability of PC3 cells and two CD44 +ve breast cancer cell lines (MDA-MB-231 and MDA-MB-157) to bind FITC-conjugated hyaluronan (FITC-HA) and to adhere to hBMECs. In contrast, transfection of DU145 cells or the T47D and MCF-7 breast cancer cell lines to express CD44s increased cell surface binding of FITC-HA and cell adherence to hBMECs. Treatment of PC3 and MDA-MD-231 cells but not hBMECs with hyaluronidase attenuated cell adhesion, suggesting that cell surface expression of CD44 on prostate and breast cancer cells may promote the retention of a HA coat that facilitates their initial arrest on bone marrow endothelium.




This article has been cited by other articles:


Home page
GlycobiologyHome page
S. R Barthel, J. D Gavino, G. K Wiese, J. M Jaynes, J. Siddiqui, and C. J Dimitroff
Analysis of glycosyltransferase expression in metastatic prostate cancer cells capable of rolling activity on microvascular endothelial (E)-selectin
Glycobiology, October 1, 2008; 18(10): 806 - 817.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
C. Rampon, N. Weiss, C. Deboux, N. Chaverot, F. Miller, D. Buchet, H. Tricoire-Leignel, S. Cazaubon, A. Baron-Van Evercooren, and P.-O. Couraud
Molecular Mechanism of Systemic Delivery of Neural Precursor Cells to the Brain: Assembly of Brain Endothelial Apical Cups and Control of Transmigration by CD44
Stem Cells, July 1, 2008; 26(7): 1673 - 1682.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
Y.-X. Zhang, P. G. Knyazev, Y. V. Cheburkin, K. Sharma, Y. P. Knyazev, L. Orfi, I. Szabadkai, H. Daub, G. Keri, and A. Ullrich
AXL Is a Potential Target for Therapeutic Intervention in Breast Cancer Progression
Cancer Res., March 15, 2008; 68(6): 1905 - 1915.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. D. McCabe, D. D. Spyropoulos, D. Martin, and C. S. Moreno
Genome-Wide Analysis of the Homeobox C6 Transcriptional Network in Prostate Cancer
Cancer Res., March 15, 2008; 68(6): 1988 - 1996.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
A. J. Najy, K. C. Day, and M. L. Day
ADAM15 Supports Prostate Cancer Metastasis by Modulating Tumor Cell-Endothelial Cell Interaction
Cancer Res., February 15, 2008; 68(4): 1092 - 1099.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
A. Ouhtit, Z. Y. Abd Elmageed, M. E. Abdraboh, T. F. Lioe, and M. H.G. Raj
In Vivo Evidence for the Role of CD44s in Promoting Breast Cancer Metastasis to the Liver
Am. J. Pathol., December 1, 2007; 171(6): 2033 - 2039.
[Abstract] [Full Text] [PDF]


Home page
Mol. Biol. CellHome page
A. Weigert, N. Tzieply, A. von Knethen, A. M. Johann, H. Schmidt, G. Geisslinger, and B. Brune
Tumor Cell Apoptosis Polarizes Macrophages Role of Sphingosine-1-Phosphate
Mol. Biol. Cell, October 1, 2007; 18(10): 3810 - 3819.
[Abstract] [Full Text] [PDF]


Home page
JCOHome page
F.-Y. Liu and T.-C. Yen
In Reply
J. Clin. Oncol., April 1, 2007; 25(10): 1297 - 1299.
[Full Text] [PDF]


Home page
Cancer Res.Home page
J. Wang, J. Wang, J. Dai, Y. Jung, C.-L. Wei, Y. Wang, A. M. Havens, P. J. Hogg, E. T. Keller, K. J. Pienta, et al.
A Glycolytic Mechanism Regulating an Angiogenic Switch in Prostate Cancer
Cancer Res., January 1, 2007; 67(1): 149 - 159.
[Abstract] [Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. S. Wicha
Cancer stem cells and metastasis: lethal seeds.
Clin. Cancer Res., October 1, 2006; 12(19): 5606 - 5607.
[Full Text] [PDF]


Home page
Clin. Cancer Res.Home page
M. Balic, H. Lin, L. Young, D. Hawes, A. Giuliano, G. McNamara, R. H. Datar, and R. J. Cote
Most early disseminated cancer cells detected in bone marrow of breast cancer patients have a putative breast cancer stem cell phenotype.
Clin. Cancer Res., October 1, 2006; 12(19): 5615 - 5621.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
A. C. Cook, A. F. Chambers, E. A. Turley, and A. B. Tuck
Osteopontin Induction of Hyaluronan Synthase 2 Expression Promotes Breast Cancer Malignancy
J. Biol. Chem., August 25, 2006; 281(34): 24381 - 24389.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. M. van Golen, T. S. Schwab, B. Kim, M. E. Soules, S. Su Oh, K. Fung, K. L. van Golen, and E. L. Feldman
Insulin-Like Growth Factor-I Receptor Expression Regulates Neuroblastoma Metastasis to Bone.
Cancer Res., July 1, 2006; 66(13): 6570 - 6578.
[Abstract] [Full Text] [PDF]


Home page
Stem CellsHome page
H. Zhu, N. Mitsuhashi, A. Klein, L. W. Barsky, K. Weinberg, M. L. Barr, A. Demetriou, and G. D. Wu
The Role of the Hyaluronan Receptor CD44 in Mesenchymal Stem Cell Migration in the Extracellular Matrix
Stem Cells, April 1, 2006; 24(4): 928 - 935.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Pathol.Home page
G M K Tse, P-H Tan, T K F Ma, C B Gilks, C S P Poon, and B K B Law
CD44s is useful in the differentiation of benign and malignant papillary lesions of the breast
J. Clin. Pathol., November 1, 2005; 58(11): 1185 - 1188.
[Abstract] [Full Text] [PDF]


Home page
Cancer Res.Home page
C. J. Dimitroff, L. Descheny, N. Trujillo, R. Kim, V. Nguyen, W. Huang, K. J. Pienta, J. L. Kutok, and M. A. Rubin
Identification of Leukocyte E-Selectin Ligands, P-Selectin Glycoprotein Ligand-1 and E-Selectin Ligand-1, on Human Metastatic Prostate Tumor Cells
Cancer Res., July 1, 2005; 65(13): 5750 - 5760.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Meeting Abstracts Online
Copyright © 2004 by the American Association for Cancer Research.